Medium Risk

Zydus Lifesciences Limited

Research and development, manufacturing, marketing, and distribution of pharmaceutical products, including active pharm

CIN: L24230GJ1995PLC025878 FY: - Revenue: ₹232,415.0 Cr
5.0
ESG Risk
Score /10
Compliance RiskGhg IntensityWater Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
1.0
EPR Exposure
5.0
Compliance Risk
10.0
HR Risk
3.0
Governance Risk
3.0

Financial Exposure

Est. Compliance Cost₹372–1394 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated32,105.2 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyYes
BRSR AssurancePartial
Assurance ProviderM/s Intertek India Private Limited

Double Materiality

Financial Materiality5.0
Impact Materiality4.6
QuadrantFinancially Material

Supply Chain

MSME Sourcing0.1%
Lifecycle AssessmentYes
Product ReclaimYes

Material Risks

e-waste

ESG Targets & Commitments

TopicTarget / MetricStatus
Life Cycle Assessment LCA conducted for products Achieved
Human Rights in Supply Chain HR clauses in all contracts Commitment

AI Risk Summary

Zydus Lifesciences Limited carries a medium ESG financial risk score of 5.0/10. Primary risk drivers are compliance risk, ghg intensity. Estimated annual compliance cost exposure: ₹372–1394 crore.

Source: Zydus Lifesciences Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →